Abstract
This issue's series of articles on ipilimumab are placed into the context of current treatment practices in melanoma.
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Drug Synergism*
-
Drug-Related Side Effects and Adverse Reactions / pathology*
-
Female
-
Humans
-
Ipilimumab
-
Male
-
Melanoma / drug therapy*
-
Melanoma / genetics*
-
Melanoma / immunology*
-
Neoplasm Metastasis / drug therapy*
-
Neoplasm Metastasis / immunology*
-
Proto-Oncogene Proteins B-raf / genetics*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / immunology*
Substances
-
Antibodies, Monoclonal
-
Ipilimumab
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf